This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Confirm mutations in the ABCA4 gene
Timeframe: 12 months
Confirm the absence of pathogenic mutations in genes known to cause retinal disease other than ABCA4-related retinopathy
Timeframe: 12 months
Measure BCVA and LLVA
Timeframe: 12 months
Measure the area of retinal atrophy
Timeframe: 12 months
Measure baseline retinal structure
Timeframe: 12 months
Historical FAF or OCT images
Timeframe: 4 years
Historical BCVA/LLVA measurements
Timeframe: 4 years
Associate Director, Clinical Operations